Literature DB >> 12812346

Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type-1.

Denise Utsch Gonçalves1, Antônio Carlos Martins Guedes, Anna Bárbara de Freitas Carneiro Proietti, Marina Lobato Martins, Fernando Augusto Proietti, José Roberto Lambertucci.   

Abstract

Dermatologic manifestations are quite common in patients with adult T cell leukemia/lymphoma and myelopathy/tropical spastic paraparesis associated with infection with human T cell lymphotropic virus type-1 (HTLV-1). In this study, we evaluated the dermatologic lesions of eligible blood donors in the state of Minas Gerais in Brazil who were seropositive but asymptomatic for infection with HTLV-1. The study population was composed of 128 HTLV-1-seropositive individuals and 108 seronegative controls. All individuals underwent a dermatologic evaluation. Biopsy specimens were obtained from abnormal and normal skin samples of seropositive individuals in an attempt to detect HTLV-1 in tissue samples by a polymerase chain reaction. Dermatologic alterations were observed more frequently in the seropositive group (adjusted odds ratio [OR] = 8.77, 95% confidence interval [CI] = 4.11-18.71). The most common skin diseases were dermatophytoses (adjusted OR = 3.32, 95% CI = 1.50-7.35), seborrheic dermatitis (OR = 3.53, 95% CI = 0.67-24.66), and acquired ichthyosis (P = 0.001). Virus was detected more frequently in abnormal skin samples. Dermatologic lesions probably related to HTLV-1 infection were diagnosed in eligible blood donors who were infected with this virus, who were previously considered to be asymptomatic carriers of HTLV-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12812346     DOI: 10.4269/ajtmh.2003.68.562

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I).

Authors:  Lorena Dantas; Eduardo Netto; Marshall J Glesby; Edgar M Carvalho; Paulo Machado
Journal:  Int J Dermatol       Date:  2013-09-30       Impact factor: 2.736

2.  Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?

Authors:  Marina Lobato Martins; Jacqueline Cronemberger Guimarães; João Gabriel Ribas; Luiz Cláudio Ferreira Romanelli; Anna Bárbara de Freitas Carneiro-Proietti
Journal:  J Neurovirol       Date:  2016-09-27       Impact factor: 2.643

Review 3.  Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

Authors:  Denise Utsch Gonçalves; Fernando Augusto Proietti; João Gabriel Ramos Ribas; Marcelo Grossi Araújo; Sônia Regina Pinheiro; Antônio Carlos Guedes; Anna Bárbara F Carneiro-Proietti
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

4.  Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome.

Authors:  Fernanda Khouri Barreto; Ricardo Khouri; Filipe Ferreira de Almeida Rego; Luciane Amorim Santos; Maria Fernanda de Castro-Amarante; Izabela Bialuk; Cynthia A Pise-Masison; Bernardo Galvão-Castro; Antoine Gessain; Steven Jacobson; Genoveffa Franchini; Luiz Carlos Alcantara
Journal:  Infect Genet Evol       Date:  2016-08-21       Impact factor: 3.342

5.  Clinical manifestations in individuals with recent diagnosis of HTLV type I infection.

Authors:  Shelene K W Poetker; Aurelia F Porto; Silvana P Giozza; Andre L Muniz; Marina F Caskey; Edgar M Carvalho; Marshall J Glesby
Journal:  J Clin Virol       Date:  2011-03-08       Impact factor: 3.168

6.  Impairment of the humoral and CD4(+) T cell responses in HTLV-1-infected individuals immunized with tetanus toxoid.

Authors:  Anselmo Souza; Silvane Santos; Lucas P Carvalho; Maria Fernanda R Grassi; Edgar M Carvalho
Journal:  Hum Immunol       Date:  2016-06-06       Impact factor: 2.850

7.  A public HTLV-1 molecular epidemiology database for sequence management and data mining.

Authors:  Thessika Hialla Almeida Araujo; Leandro Inacio Souza-Brito; Pieter Libin; Koen Deforche; Dustin Edwards; Antonio Eduardo de Albuquerque-Junior; Anne-Mieke Vandamme; Bernardo Galvao-Castro; Luiz Carlos Junior Alcantara
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

8.  Interferon-γ Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice.

Authors:  Yu Mitagami; Jun-Ichirou Yasunaga; Haruka Kinosada; Koichi Ohshima; Masao Matsuoka
Journal:  PLoS Pathog       Date:  2015-08-21       Impact factor: 6.823

9.  Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disorders.

Authors:  Jordana Grazziela Alves Coelho-dos-Reis; Livia Passos; Mariana Costa Duarte; Marcelo Grossi Araújo; Ana Carolina Campi-Azevedo; Andréa Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Bruno Caetano Trindade; Raquel Dos Santos Dias; Marina Lobato Martins; Anna Barbara de Freitas Carneiro-Proietti; Antônio Carlos Guedes; Denise Utsch Gonçalves; Olindo Assis Martins-Filho
Journal:  PLoS Negl Trop Dis       Date:  2013-07-25

10.  High prevalence of skin disorders among HTLV-1 infected individuals independent of clinical status.

Authors:  Renata Okajima; Augusto C P Oliveira; Jerusa Smid; Jorge Casseb; Jose Antonio Sanches
Journal:  PLoS Negl Trop Dis       Date:  2013-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.